Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 43

1.

The Trauma of Dialysis Initiation.

Hercz G.

J Am Soc Nephrol. 2017 Oct;28(10):2835-2837. doi: 10.1681/ASN.2017020212. Epub 2017 Aug 28. No abstract available.

PMID:
28848001
2.

The absentee hemodialysis patient.

Hercz G.

CANNT J. 2014 Apr-Jun;24(2):50. No abstract available.

PMID:
25276991
3.

Facilitating communication with the patient with a language barrier.

Hercz G, Novak M.

CANNT J. 2014 Oct-Dec;24(4):29. No abstract available.

PMID:
29218979
4.

Addressing quality of life and end-of-life decisions with patients.

Hercz G, Novak M.

CANNT J. 2014 Jan-Mar;24(1):34. No abstract available.

PMID:
24783771
5.

The challenges presented by the non-compliant patient.

Hercz G, Novak M.

CANNT J. 2013 Oct-Dec;23(4):30. No abstract available.

PMID:
24660522
6.

Understanding the hemodialysis patient with dementia.

Hercz G.

CANNT J. 2013 Jul-Sep;23(3):38-9. No abstract available.

PMID:
24344522
7.

The 5th modality: psychonephrology.

Novak M, Hercz G.

CANNT J. 2013 Apr-Jun;23(2):59-60. No abstract available.

PMID:
24069701
8.

Development and utility of a multi-dimensional grid to assess individual mineral metabolism control in hemodialysis patients: A potential aid for therapeutic decision making?

Morton AR, Murphy S, Hirsch D, Leblanc M, Barré P, Lok C, Hercz G, Hodsman A, Reslerova M, Levin A.

Hemodial Int. 2010 Apr;14(2):200-10. doi: 10.1111/j.1542-4758.2009.00426.x. Epub 2010 Mar 12.

PMID:
20337745
9.

The effects of discontinuing cinacalcet at the time of kidney transplantation.

Jadoul M, Baños A, Zani VJ, Hercz G.

NDT Plus. 2010 Feb;3(1):37-41. Epub 2009 Dec 4.

10.

The natural history of the non-nephrotic membranous nephropathy patient.

Hladunewich MA, Troyanov S, Calafati J, Cattran DC; Metropolitan Toronto Glomerulonephritis Registry.

Clin J Am Soc Nephrol. 2009 Sep;4(9):1417-22. doi: 10.2215/CJN.01330209. Epub 2009 Aug 6.

11.

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.

Fellström BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, Chae DW, Chevaile A, Cobbe SM, Grönhagen-Riska C, De Lima JJ, Lins R, Mayer G, McMahon AW, Parving HH, Remuzzi G, Samuelsson O, Sonkodi S, Sci D, Süleymanlar G, Tsakiris D, Tesar V, Todorov V, Wiecek A, Wüthrich RP, Gottlow M, Johnsson E, Zannad F; AURORA Study Group.

N Engl J Med. 2009 Apr 2;360(14):1395-407. doi: 10.1056/NEJMoa0810177. Epub 2009 Mar 30. Erratum in: N Engl J Med. 2010 Apr 15;362(15):1450.

12.

Switching to lanthanum carbonate monotherapy provides effective phosphate control with a low tablet burden.

Hutchison AJ, Laville M; SPD405-313 Lanthanum Study Group.

Nephrol Dial Transplant. 2008 Nov;23(11):3677-84. doi: 10.1093/ndt/gfn310. Epub 2008 Jun 24.

13.

Telmisartan is more effective than losartan in reducing proteinuria in patients with diabetic nephropathy.

Bakris G, Burgess E, Weir M, Davidai G, Koval S; AMADEO Study Investigators.

Kidney Int. 2008 Aug;74(3):364-9. doi: 10.1038/ki.2008.204. Epub 2008 May 21.

14.

The impact of sex in primary glomerulonephritis.

Cattran DC, Reich HN, Beanlands HJ, Miller JA, Scholey JW, Troyanov S; Genes, Gender and Glomerulonephritis Group.

Nephrol Dial Transplant. 2008 Jul;23(7):2247-53. doi: 10.1093/ndt/gfm919. Epub 2008 Jan 8.

PMID:
18182409
16.

Reversal of adynamic bone disease by lowering of dialysate calcium.

Haris A, Sherrard DJ, Hercz G.

Kidney Int. 2006 Sep;70(5):931-7. Epub 2006 Jul 12.

17.

Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis.

Block GA, Martin KJ, de Francisco AL, Turner SA, Avram MM, Suranyi MG, Hercz G, Cunningham J, Abu-Alfa AK, Messa P, Coyne DW, Locatelli F, Cohen RM, Evenepoel P, Moe SM, Fournier A, Braun J, McCary LC, Zani VJ, Olson KA, Drüeke TB, Goodman WG.

N Engl J Med. 2004 Apr 8;350(15):1516-25.

18.

Association between fluoride, magnesium, aluminum and bone quality in renal osteodystrophy.

Ng AH, Hercz G, Kandel R, Grynpas MD.

Bone. 2004 Jan;34(1):216-24.

PMID:
14751580
19.

Regulation of bone remodeling: impact of novel therapies.

Hercz G.

Semin Dial. 2001 Jan-Feb;14(1):55-60. Review.

PMID:
11208041
20.

Screening plasma aluminum levels in relation to aluminum bone disease among asymptomatic dialysis patients.

Kausz AT, Antonsen JE, Hercz G, Pei Y, Weiss NS, Emerson S, Sherrard DJ.

Am J Kidney Dis. 1999 Oct;34(4):688-93.

PMID:
10516350

Supplemental Content

Loading ...
Support Center